The National Center for Cancer Care and Research (NCCCR) is the premier and only dedicated cancer hospital in the State of Qatar. It provides comprehensive care for patients requiring ongoing treatments such as chemotherapy, targeted hormone immunotherapy and radiotherapy. NCCCR also manages both benign and malignant hematological disorders and offers Bone Marrow Transplants, palliative care, and a specialized pain management clinic. Surgical oncology services are delivered through NCCCR’s partner facility, Hamad General Hospital.

• Medical Oncology (chemotherapy, immunotherapy, targeted therapy)

• Radiation Oncology (linear accelerators, cyberknife, brachytherapy, TrueBeam, ETHOS)

• Hematology (malignant and benign disorders, bone marrow transplants)

• Palliative Care and Pain Management

• Supportive Clinics (genetic counseling, cardio-oncology, survivorship)

• Outpatient clinics, infusion suites, urgent care, short-stay, and home chemotherapy services

• Multidisciplinary tumor boards

• Surgical Oncology (in partnership with Hamad General Hospital)

• International standards: Accredited by JCI and ESMO, NCCCR is recognized for safety, effectiveness, and patient-centered care.

• Fast access: Over 90% of suspected cancer patients are seen within 48 hours of referral.

• Personalized care: Multidisciplinary teams develop individualized treatment plans.

• Continuous improvement: Active participation in national and regional cancer strategies, evidence-based protocols, rigorous staff training, and frequent quality audits.

• Home-based services: Launch of home chemotherapy and palliative care for eligible patients as part of Qatar Cancer Plan 2023-2026.

Vision:
To become an internationally recognized, world-class center for healthcare excellence.

Mission:
To deliver optimal treatment and care for patients with cancer and blood disorders using compassion, excellence, state-of-the-art technology, education, and quality improvement through a multidisciplinary team.

• JCI Accreditation for the Supportive and Palliative Care Program (2012, 2015)

• First Place, Best of American Society of Clinical Oncology (ASCO) – Qatar Conference (2023), for oncology research

• Multiple group and team recognitions for innovation, excellence, and research within HMC and the Gulf region

• Center is noted for high survival rates and its leadership in precision cancer care